Suppr超能文献

对于我们最喜欢的药妆成分,我们究竟了解多少?

How much do we really know about our favorite cosmeceutical ingredients?

作者信息

Levin Jacquelyn, Momin Saira B

机构信息

Dr. Levin is from the Mohave Skin & Cancer Clinics, Dermatology Research Center, Las Vegas, Nevada.

出版信息

J Clin Aesthet Dermatol. 2010 Feb;3(2):22-41.

Abstract

To date, we are unaware of a review that has investigated common cosmeceutical ingredients in order to answer the three specific questions proposed by the father of cosmeceuticals, Dr. Albert Kligman. It is the goal of this review to gather all the published scientific data on five common cosmeceutical ingredients, answer the three major questions about the scientific rationale for their use, and ascertain how much we really know about consumers' favorite cosmeceutical ingredients.Most of the research concerning cosmeceutical retinoid ingredients is based upon the effects of retinoic acid on the skin. Clinical trials concerning retinol and retinaldehyde are scant and lacking in statistical evaluation for significance. There is research substantiating the effects of kinetin in plants and also in-vitro antioxidant effects. However, proof of anti-aging activity remains elusive, and the clinical efficacy of kinetin is based on limited data. Niacinamide is the ingredient investigated that most closely upholds the "Kligman standards" of cosmeceutical-ingredient analysis. With the available scientific evidence on topical niacinamide, clinicians are able to adequately answer questions about permeability, mechanism, and clinical effect. Both green tea and soy have been popularized commercially based on their antioxidant effects, yet there is a paucity of clinical studies concerning their efficacy as topical anti-aging agents. It may be that soy and green tea are better at preventing the signs and symptoms of skin aging than actually reversing them. Since cosmeceutical products are claiming to therapeutically affect the structure and function of the skin, it is rational and necessary to hold them to specified scientific standards that substantiate efficacy claims.

摘要

迄今为止,我们尚未发现有综述研究过常见的药妆成分,以回答药妆之父阿尔伯特·克利格曼博士提出的三个具体问题。本综述的目的是收集关于五种常见药妆成分的所有已发表科学数据,回答关于其使用科学依据的三个主要问题,并确定我们对消费者喜爱的药妆成分究竟了解多少。

大多数关于药妆类视黄醇成分的研究都是基于视黄酸对皮肤的影响。关于视黄醇和视黄醛的临床试验很少,且缺乏统计学意义评估。有研究证实了激动素在植物中的作用以及体外抗氧化作用。然而,抗衰老活性的证据仍然难以捉摸,激动素的临床疗效基于有限的数据。烟酰胺是所研究的成分中最符合药妆成分分析“克利格曼标准”的。根据现有的关于局部使用烟酰胺的科学证据,临床医生能够充分回答关于渗透性、作用机制和临床效果的问题。绿茶和大豆都因其抗氧化作用而在商业上得到推广,但关于它们作为局部抗衰老剂的疗效的临床研究却很少。可能大豆和绿茶在预防皮肤衰老的迹象和症状方面比实际逆转它们更有效。由于药妆产品声称对皮肤的结构和功能有治疗作用,因此按照证实功效宣称的特定科学标准来要求它们是合理且必要的。

相似文献

7
Cosmeceuticals: undefined, unclassified, and unregulated.药妆品:定义不明确、未分类且不受监管。
Clin Dermatol. 2009 Sep-Oct;27(5):431-4. doi: 10.1016/j.clindermatol.2009.05.005.
8
The use of natural ingredients in innovative Korean cosmeceuticals.天然成分在创新型韩国药妆品中的应用。
J Cosmet Dermatol. 2018 Jun;17(3):305-312. doi: 10.1111/jocd.12492. Epub 2018 Jan 24.

引用本文的文献

5
Photoprotective properties of new derivatives of kinetin.激动素新衍生物的光保护特性
Photochem Photobiol Sci. 2023 Feb;22(2):357-369. doi: 10.1007/s43630-022-00320-1. Epub 2022 Oct 20.
9
The Application of Skin Care Product in Melasma Treatment.护肤品在黄褐斑治疗中的应用。
Clin Cosmet Investig Dermatol. 2021 Sep 7;14:1165-1171. doi: 10.2147/CCID.S323748. eCollection 2021.

本文引用的文献

1
Cosmeceuticals: are they truly worth the cost?药妆品:它们真的物有所值吗?
Indian J Dermatol Venereol Leprol. 2009 Jan-Feb;75(1):8-9. doi: 10.4103/0378-6323.45213.
3
Cosmeceuticals: focus on topical retinoids in photoaging.药妆品:聚焦于光老化中的局部维甲酸类药物。
Clin Dermatol. 2008 Nov-Dec;26(6):633-5. doi: 10.1016/j.clindermatol.2007.09.016.
4
Efficacy and safety of innovative cosmeceuticals.创新药妆品的功效与安全性。
Clin Dermatol. 2008 Jul-Aug;26(4):367-74. doi: 10.1016/j.clindermatol.2008.01.013.
5
Cosmeceuticals.药妆品
Clin Dermatol. 2008 Jul-Aug;26(4):317. doi: 10.1016/j.clindermatol.2008.05.005.
6
Topical vitamins.外用维生素
J Drugs Dermatol. 2008 Jul;7(7 Suppl):s2-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验